03:18 AM EDT, 05/14/2025 (MT Newswires) -- Andrew Cheng, Director, President and Chief Executive Officer, on May 12, 2025, sold 30,000 shares in Akero Therapeutics ( AKRO ) for $1,244,455. Following the Form 4 filing with the SEC, Cheng has control over a total of 594,324 common shares of the company, with 594,324 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1744659/000095017025070811/xslF345X05/ownership.xml